Pricing Log in Create free account

Assembly Biosciences, Inc. (ASMB) vs MapLight Therapeutics, Inc. (MPLT)

Assembly Biosciences, Inc. and MapLight Therapeutics, Inc. are both Biotechnology companies. Assembly Biosciences, Inc. and MapLight Therapeutics, Inc. are of similar size ($490.7M and $479.1M). MapLight Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Assembly Biosciences, Inc. trades at 22.3×. MapLight Therapeutics, Inc. has the higher net margin (0.00% vs −0.06%) and the lower return on invested capital (−348.4% vs 0.00%). Across the 12 metrics below, Assembly Biosciences, Inc. leads on 6 and MapLight Therapeutics, Inc. on 6.

Valuation

Metric ASMB MPLT Biotechnology median
P/E 22.32 n/m 8.56
P/S 5.74 n/m 10.17
P/B 1.40 1.12 2.34
Price to free cash flow n/m n/m 20.42
EV/EBITDA n/m n/m 0.69
EV/Sales 1.46 n/m 9.64
Earnings yield 4.48% (491.98%) (29.41%)
Free cash flow yield (8.98%) (44.82%) (23.50%)

Profitability

Metric ASMB MPLT Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (11.75%) 0.00% 0.00%
Net margin (0.06%) 0.00% 0.00%
Free cash flow margin (51.53%) 0.00% 0.00%
Return on equity (0.03%) (297.18%) (56.66%)
Return on assets (0.02%) (124.79%) (49.22%)
Return on invested capital 0.00% (348.44%) 0.00%

Growth

Metric ASMB MPLT Biotechnology median
Revenue growth (TTM) 125.12% — 5.64%
EPS growth (last fiscal year) 91.78% 82.39% 30.08%
Revenue growth, 5-year CAGR 35.27% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ASMB MPLT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.99 16.52 4.72
Net debt to EBITDA 17.31 1.79 0.96

Dividend

Metric ASMB MPLT Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ASMB MPLT Biotechnology median
Market cap 479.08m 490.73m 151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack